Grossman Adam S sold ADMA
December 15, 2025 · Form 4 insider transaction
Grossman Adam S sold 15,000 shares of ADMA Biologics, Inc. at $19.79 per share, a transaction worth $296.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$19.79
Total value
$296.9K
InsiderGrossman Adam S
RoleOfficer, Director
CompanyADMA Biologics, Inc. (ADMA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 15, 2025
Filing dateDecember 16, 2025
Shares owned after2,013,850
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer.; The price reported in Column 4 is the price at which the shares were sold.